Surgical Robots Industry Overview

The global surgical robots market size was estimated at USD 3.92 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 9.5% from 2024 to 2030.

Shortage of physicians and surgeons across the globe and increasing adoption of automated instruments used for surgery are major factors driving market growth. Furthermore, growing prevalence of bone degenerative diseases and rising number of hip & knee replacement surgeries due to increasing cases of arthritis & osteoporosis are anticipated to drive growth. For instance, according to the Agency for Healthcare Research and Quality report, over 4,50,000 hip replacement surgeries are performed annually in the U.S.

Gather more insights about the market drivers, restrains and growth of the Surgical Robots Market

An increasing number of knee and hip replacement surgeries is one of the key factors anticipated to drive the adoption of surgical robots in healthcare industry. Some major disorders that affect joints are various types of arthritis, bone degenerative diseases, and osteoporosis. Rising prevalence of these conditions has led to an increase in the number of patients requiring knee and hip replacement surgeries.

As per the Australian Institute of Health and Welfare (AIHW) statistics, total knee replacement rate for osteoarthritis increased by about 38% from 2005-2006 to 2017-2018. According to the International Congress for Joint Reconstruction in March 2018, total number of primary hip replacement and knee replacement procedures is projected to reach 635,000 (171.0% increase) & 1.28 million (189.0% increase), respectively, by 2030 and 1.23 million (330.0% growth) & 2.60 million (382.0% growth) by 2060.

According to an article published by The Regents of the University of California in March 2017, total hip replacements are expected to increase by almost 200%, and total knee replacements performed in the U.S. are expected to increase by more than 600% by 2030 compared to 2005. This is driving the adoption of surgical robots, thereby aiding market growth. Furthermore, the postoperative functional outcome for patients is another significant growth driver. Robotic surgery supports surgeons in performing complicated procedures with greater flexibility, precision, and control over conventional surgeries.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global plastic surgery instruments market size was valued at USD 1.42 billion in 2023 and is projected to grow at a CAGR of 7.7% from 2024 to 2030.
• The global aesthetic lasers market size was valued at USD 1.30 billion in 2023 and is projected to grow at a CAGR of 16.8% from 2024 to 2030.

Surgical Robots Market Segmentation

Grand View Research has segmented the global surgical robots market based on application, end-use, and region:

Surgical Robots Application Outlook (Revenue, USD Million, 2018 - 2030)

• Orthopedics
• Neurology
• Urology
• Gynecology
• Others

Surgical Robots End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Inpatient
• Outpatient

Surgical Robots Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • Italy
  • France
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Key Companies profiled:

• Intuitive Surgical
• Medrobotics Corporation
• Medtronic
• Renishaw plc
• Smith and Nephew
• Stryker Corporation
• THINK Surgical, Inc.
• TransEnterix (Asensus Surgical, Inc.)
• Zimmer Biomet Holdings, Inc.

Key Surgical Robots Company Insights

Key companies are increasingly focusing on introducing innovative technologies and entering into various strategic collaborations with orthopedic centers & other industry players to acquire new capabilities in surgical robots to maintain their competitive edge. Companies are also undertaking other strategies, such as new product launches and collaborations & partnerships. Moreover, rising demand for automated surgical instruments globally is likely to promote the entry of new companies into the market. For instance:

• In January 2021, DePuy Synthes (Johnson & Johnson) received FDA approval for its VELYS robotic system, improving its offerings with the ATTUNE TOTAL knee system. The entry of DePuy Synthes into the robotics surgical domain indicates a continuous and promising trend in the adoption of robotics for joint replacement surgeries
• In January 2022, Smith & Nephew acquired Engage Surgical, which is involved in manufacturing cementless knee systems in the U.S. This acquisition improved its position in meniscal tear solutions and other knee arthroscopy devices
• In August 2023, Stryker launched a direct patient marketing campaign aimed at enhancing patient engagement and education. The campaign is designed to reach patients directly & provide information about Stryker's innovative medical solutions, focusing on joint replacement procedures. By fostering better patient understanding & awareness, Stryker aims to empower individuals to make informed decisions about their healthcare, ultimately improving their overall experience and outcomes

Order a free sample PDF of the Surgical Robots Market Intelligence Study, published by Grand View Research.